Maxpee 0.4mg Tablet MR
Marketer
Mediarch Healthcare Private Limited
Salt Composition
Tamsulosin (0.4mg)
Overview Maxpee 0.4mg Tablet MR
Alfaprost 0.4mg Extended-Release Tablet is an alpha-blocker indicated for benign prostatic hyperplasia (BPH). It alleviates urinary symptoms such as hesitancy, but doesn't reduce prostate volume. Always follow your doctor's prescribed dosage and regimen. This medication can be taken with or without food, but maintain consistent timing. Swallow the tablet whole; do not crush or chew. Discontinuing treatment prematurely may worsen symptoms; complete the prescribed course for optimal results. Common side effects include lightheadedness, backache, chest discomfort, impaired ejaculation, and retrograde ejaculation. Report persistent or bothersome side effects immediately to your physician. Lifestyle modifications can aid symptom management. Urinate promptly when the urge arises, but avoid straining. Limit evening and pre-sleep consumption of caffeine and alcohol. Disclose all current medications to your doctor before starting treatment. If cataract or glaucoma surgery is planned, inform your ophthalmologist about Alfaprost use. Patients with hepatic impairment require close monitoring and regular check-ups as directed by their doctor.
Primary Ingredients of Maxpee 0.4mg Tablet MR
No information provided. Please provide the text you wish me to rewrite.
Uses of Maxpee 0.4mg Tablet MR
Managing benign prostatic enlargement
Major Benefits of Maxpee 0.4mg Tablet MR:
Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Maxpee 0.4mg Modified-Release Tablets may be consumed with or without food, although consistent daily timing is recommended.
Common Side effects of Maxpee 0.4mg Tablet MR:
- Chest pain
- Inflammation of the nose
- Dizziness
- Ejaculation disorder
- Headache
- Abdominal pain
- Back pain
- Nausea
- Infection
How to use Maxpee 0.4mg Tablet MR:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Maxpee 0.4mg Modified-Release Tablet can be consumed with or without food, though consistent timing is recommended.
How Maxpee 0.4mg Tablet MR works:
Maxpee 0.4mg Modified-Release tablets are alpha-adrenergic antagonists. Their mechanism of action involves relaxing the bladder neck and prostate muscles, facilitating smoother urine flow. This promotes complete bladder emptying and lessens urinary frequency and urgency associated with benign prostatic hyperplasia (BPH).
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Maxpee 0.4mg modified-release tablets and alcohol may result in pronounced somnolence.
PregnancyCONSULT YOUR DOCTOR
Data on Maxpee 0.4mg Tablet MR use in pregnancy is lacking. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Using Maxpee 0.4mg Tablet MR while breastfeeding is likely unsafe. Available data suggests potential transfer to breast milk, posing a risk to the infant. This medication is contraindicated for women.
DrivingSAFE
Driving ability is typically unaffected by Maxpee 0.4mg Tablet MR.
KidneySAFE IF PRESCRIBED
Maxpee 0.4mg MR tablets are considered safe for patients with kidney impairment, and no dosage alteration is advised. Data on Maxpee 0.4mg MR tablet use in those with end-stage renal disease is, however, scarce. Physician consultation is recommended.
LiverCAUTION
Individuals with severe hepatic impairment should exercise caution when using Maxpee 0.4mg MR tablets. A modified dosage of Maxpee 0.4mg MR tablets may be necessary. Physician consultation is advised.
What if you forget to take Maxpee 0.4mg Tablet MR :
Should you forget a Maxpee 0.4mg MR Tablet dose, take it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Maxpee 0.4mg Tablet MR
| Label | Value |
|---|---|
| Chemical Type | Sulfonamide-based compound |
| Developing Habits | No. |
| Treatment Category | Urological Care |




